Why did Echo IQ (ASX:EIQ) raise $110 million?

Echo IQ (ASX:EIQ) raised the capital to secure funds required to seek to execute its commercial expansion strategy in the United States. The company stated that the money will also assist with accelerating the development of its expanding artificial intelligence product portfolio.

Echo IQ (ASX:EIQ) raised the capital to secure funds required to seek to execute its commercial expansion strategy in the United States. The company stated that the money will also assist with accelerating the development of its expanding artificial intelligence product portfolio.

What are the pricing details for the Echo IQ (ASX:EIQ) share placement? Echo IQ (ASX:EIQ) priced the new shares at A$1.45 each, which represents an 8.8% discount to its last traded price on June 26. This institutional placement will result in the issuance of 75,862,069 new ordinary shares.

How much dilution will current Echo IQ (ASX:EIQ) shareholders experience?

The placement will result in the issue of 75,862,069 new shares, representing approximately 11.5% of the current issued capital of Echo IQ (ASX:EIQ). These shares will rank equally in all respects with existing ordinary shares.

What is the completion timeline for the Echo IQ (ASX:EIQ) capital raise?

Settlement of the new shares issued under the Echo IQ (ASX:EIQ) placement is expected to occur on July 6. The new shares are scheduled to commence trading on the ASX on July 7.

Which international markets is Echo IQ (ASX:EIQ) targeting with this capital?

Echo IQ (ASX:EIQ) is targeting commercial expansion within the United States health system. The company stated that the proceeds will support deployment across US health systems following partnerships with Pro Medicus and Mayo Clinic.

Image for illustrative purposes only. Not a real photo.

Echo IQ raises $110M in institutional placement

Written by Brie CarterPublished Jul 1, 2026, 1:30 AM

Echo IQ has secured firm commitments to raise approximately $110 million through an institutional share placement.
The placement shares are priced at $1.45 each, representing an 8.8% discount to the last traded price.
The company stated that the capital will fund US commercial expansion and accelerate its artificial intelligence product pipeline.

Artificial intelligence and medical technology company Echo IQ (ASX:EIQ) has secured firm commitments to raise approximately $110 million.

The capital raising price of $1.45 per share represents an 8.8% discount to the last traded price on June 26.

The company will issue 75,862,069 new fully paid ordinary shares, which represent approximately 11.5% of its current issued capital.

Settlement of the new shares is scheduled for 6 July 2026, with trading expected to begin on July 7.

Following the announcement, the Echo IQ share price was unchanged at $1.59.

The capital raising follows commercial partnerships with Pro Medicus and Mayo Clinic alongside FDA clearance for its EchoSolv AS software.

The company stated the proceeds will fund US expansion and its cardiovascular platform.

Echo IQ raises $110M in institutional placement

Frequently asked questions

Assets related to this article